Geron to Resume Stem-Cell Study - Wall Street Journal

[INCIID News Feed]

USA Today
<img alt="" height="1" width="1" />
Geron to Resume Stem-Cell Study
Wall Street Journal
Geron Corp. said Friday it can proceed with early testing of an embryonic-stem-cell treatment for spinal-cord injuries after the Food and Drug Administration lifted a nearly yearlong hold on the trials. Shares of the Menlo Park, Calif., ...
Geron says FDA lifts hold on stem cell trialThe Associated Press
Geron Cleared By US Regulators to Test Embryonic Stem-Cell TreatmentBloomberg
Landmark embryonic stem cell study to proceedCNN (blog)
USA Today -Financial Times -MarketWatch
all 129 news articles &raquo;


More...